MPI Research, in partnership with INVICRO, which has a range of imaging services and software solutions, and 3D Imaging, has broken ground on its new imaging center, set to open next spring at MPI Research’s corporate headquarters in Mattawan, Mich.
Pharmaceutical researchers will have access to a cyclotron facility directly connected to a vivarium, permitting drug radiolabeling and in-depth study across a wide variety of animal models.
The 10,000-square-foot imaging center is a joint effort of MPI Research, INVICRO and 3D Imaging, which have collaborated on more than 100 imaging projects. The multimillion-dollar project will leverage the strengths of each partner, including INVICRO's molecular imaging informatics team and 3D Imaging's radiopharmaceutical group.
"The imaging center at MPI Research will offer translational imaging capabilities all under one roof," said Jack Hoppin, Ph.D., co-founder and managing partner of INVICRO. "This will fill a void not being addressed anywhere in the world and, most importantly, will speed drug discovery and development programs to market."
Many of the expanded imaging solutions, including nonhuman primate PET and CT imaging capabilities, became available in July.
"Together with our partners, we are creating a total translational imaging tool," said Marc Berridge, Ph.D., president and founder of 3D Imaging. "It will take drug development to the next level by providing biotech and pharmaceutical companies with key information never before available."